Similar content being viewed by others
References
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288: 2981–2997
Davis BR et al. (2004) ALLHAT: setting the record straight. Ann Intern Med 141: 39–46
Houston MC (2004) ALLHAT debate: diuretics are not preferred, first-line initial therapy for hypertension. Arch Intern Med 164: 570–571
Morganti A (2005) Should a diuretic always be the first choice in patients with essential hypertension? The case for no. J Am Soc Nephrol 16 (Suppl 1): S70–S73
Messerli FH et al. (2004) Antihypertensive therapy and new onset diabetes. J Hypertens 22: 1845–1847
Wilmer WA et al. (2003) Management of glomerular proteinuria: a commentary. J Am Soc Nephrol 14: 3217–3232
Bloch MJ and Basile J (2006) Valsartan but not valsartan+ hydrochlorothiazide, moderately decreases C-reactive protein in patients with stage 2-hypertension: the Val-MARC trial. J Clin Hypertens (Greenwich) 8: 602–604
Hawkins RG and Houston MC (2005) Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens 18: 744–749
Smith NL et al. (2006) New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study. Diabetes Care 29: 2012–2017
The National Heart, Lung, and Blood Institute Working Group on Future Directions in Hypertension Treatment Trials (2005) Major clinical trials of hypertension: what should be done next? Hypertension 46: 1–6
Yusuf S et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342: 145–153
PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041
Fox KM et al. (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362: 782–788
Acknowledgements
Supported in part by NIH grants PO1 DK 55546, U01 DK 39485, U01 DK 48621 and MO1 RR 00024.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hebert, L., Rovin, B. & Hebert, C. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort. Nat Rev Nephrol 3, 60–61 (2007). https://doi.org/10.1038/ncpneph0391
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0391
- Springer Nature Limited
This article is cited by
-
Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker
Kidney International (2007)